Teva Announces Approval of COPAXONE(R) in Japan for the Prevention of Relapse of Multiple Sclerosis

JERUSALEM--(Healthcare Sales & Marketing Network)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) announced today the approval by the Japanese Ministry of Health, Labour and Welfare (MHLW) of once-daily COPAXONE® (glatiramer acetate injection... Biopharmaceuticals, Neurology, RegulatoryTeva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news